PRESTON CAPITAL

Thesis

Preston Capital's investment thesis is centered on life settlements and longevity-contingent investments, which they believe offer an uncorrelated risk/return profile compared to traditional and alternative asset classes. Their strategy involves sourcing and managing diversified pools of these assets, leveraging sophisticated data sets and analytics to evaluate and mitigate risks. They also engage in opportunistic buying and exiting of policies to derive maximum value for investors. The firm's operations are primarily within the United States, with offices in Aliso Viejo, California, and Austin, Texas. Preston Capital focuses on managing life settlements, which are existing life insurance policies purchased in the secondary market. They do not appear to invest in traditional venture capital stages. Their strategy involves the acquisition, disposition, financing, valuation, and management of these assets. As of September 30, 2025, Preston Capital managed over $3.4 billion in equity capital and $8 billion in face value of life settlements. Another report from December 31, 2024, states a total regulatory AUM of $1,256,675,622, with $1,054,611,662 in discretionary AUM. The firm has never raised external funding, indicating it is privately held and funded. Information on typical check sizes per investment deal is not publicly available. The firm was founded in 2014 and is legally known as Preston Capital, LLC. Key stakeholders include David Posnick, Jon Nelson, Jonathan Hogan, and Jonathan Brooks. The firm's founders have been involved in the life settlement industry since 2004, and the senior team collectively has over 240 years of experience in life settlements.